Article
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors.
Scientific reports - 14 Nov 2024
Shahbazi Mohammad, Wheeler Heather E, Armstrong Gregory T, Frisina Robert D, Travis Lois B, Dolan M Eileen
Abstract excerpt
Tinnitus is a common sensorineural complication that can occur de novo or after cancer treatments involving cisplatin or radiotherapy. Considering the heterogeneous etiology and pathophysiology of tinnitus, the extent to which shared genetic risk factors contribute to de novo tinnitus and cancer treatment-induced tinnitus is not clear. Here we report a GWAS for de novo tinnitus using the UK Biobank cohort with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
